Schedule 13G ownership disclosure
Lexeo Therapeutics Inc
Security class unavailable · CUSIP: 52886X107
Event date: 2023-11-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,002,831
- Percent of class
- 11.9300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001580642-23-006642
- Form type
- SC 13G
- Filer
- EVENTIDE ASSET MANAGEMENT, LLC
- CIK
- CIK 1442891
- Filed
- Dec 11, 2023
- Reporting period
- Nov 30, 2023
- Description
- Schedule 13G beneficial ownership